Imo you did not understand what AT1 is actually developing. As mentioned so many times they simply develop the hardware that can accommodate any number of blood testing (for people and veterinary usage) ... Their revenue will grow with scalability and they are in the first phase of the process this year. What they did with NG Bio can be done with many other companies that will develop test strips.
Potential SP Valuation of AT1 - 80 cents to 1.30/share, page-893
-
- There are more pages in this discussion • 496 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
